Surface chemistry for high-contrast fluorescence kidney imaging

高对比度荧光肾脏成像的表面化学

基本信息

批准号：
9110279
负责人：
Jie Zheng
金额：
$ 33.01万
依托单位：
UNIVERSITY OF TEXAS DALLAS
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-09-01 至 2019-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9110279
关键词：
Address Adsorption Adult Behavior Blood Blood flow Caliber Cardiac Output Charge Chemistry Clinical Trials Contrast Media Detection Development Disease Engineering Exhibits Fluorescence Foundations Future Glutathione Gold Health Care Costs Hydrophobic Interactions Hydrophobicity Image Imagery Imaging Techniques Investigation Kidney Kidney Diseases Kidney Neoplasms Kinetics Ligands Liver Molecular Near-infrared optical imaging Operative Surgical Procedures Organism Outcome Pathology Permeability Physiological Processes Plasma Play Polyethylene Glycols Positron-Emission Tomography Radioactive Tracers Renal carcinoma Renal clearance function Research Resistance Reticuloendothelial System Serum Proteins Skin Skin Tissue Solid Specificity Surface Surgeon Time Tissues Toxic effect Translating United States Urinary system Work biomaterial compatibility body system cancer imaging clinical practice contrast enhanced contrast imaging cost disease diagnosis drug development fluorescence imaging fluorophore image guided imaging probe improved in vivo kidney imaging kidney surgery mouse model nanoparticle nanoprobe nanotoxicity pre-clinical public health relevance radiological imaging single photon emission computed tomography success tool tumor uptake

项目摘要

DESCRIPTION In vivo fluorescence imaging, allowing the visualization of physiological processes in an intact living organism, has been an indispensable preclinical tool for fundamental understandings of disease pathology and development. More recently, it has also been translated into clinical trials to improve surgery outcomes and lower health-care costs. However, delivery of in vivo fluorescence imaging into preclinical kidney research and surgery remains highly challenging because of undesired in vivo behaviors such as rapid kidney clearance and high accumulation in background tissues of current NIR emitting contrast agents. As a result, in vivo kidney imaging remains heavily relied on high-cost radiological imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), which not only limits fundamental kidney research but also makes it challenging for surgeons to conduct imaging-guided kidney surgery in the future. The objective of this application to address these critical challenges by developing a class of renal clearable near infrared (NIR) emitting nanoprobes with high kidney-targeting specificity, tunable kidney retention time and minimum accumulation in normal background tissues and reticuloendothelial system (RES) organs, so that both noninvasive and invasive kidney imaging can be achieved at high contrast with desired detection time window.

描述体内荧光成像，允许在完整的生物体中可视化生理过程，一直是对疾病病理学和发育的基本理解的必不可少的临床前工具。最近，它也已转化为临床试验，以改善手术结果并降低医疗费用。然而，由于不希望的体内行为，例如快速肾脏清除率和当前NIR发射造影剂的背景组织中的高肾脏清除率和高积累，体内荧光成像将成像递送到临床前肾脏研究和手术中仍然具有很高的挑战。结果，体内肾脏成像仍然在很大程度上依赖于高成本放射学成像技术，例如正电子发射断层扫描（PET）和单光子发射计算机断层扫描（SPECT），这不仅限制了基本肾脏研究，而且还限制了外科医生在未来进行成像肾脏手术的挑战。通过开发具有较高肾脏靶向特异性的纳米探针，可调节的肾脏保留时间和在正常背景组织中的最小积累和在网状内皮系统（Res Res）器官（res）器官中，可以在不相处的范围内，可以在不相处的范围内，可以在正常的背景组织（RES）中，因此可以在不相处的范围内，可以在正常的背景组织（RES）中，可以在正常的背景组织（RES）范围内，可以在正常的背景组织（RES）中置于高度的范围，从而在正常背景组织（RES）中造成了高度的指出。